(Q38090988)

28 August 2017

Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk (English)

1 reference

28 August 2017

0 references

1 reference

Alexandre Boyer

1

1 reference

28 August 2017

Didier Gruson

2

1 reference

28 August 2017

Stéphane Bouchet

3

1 reference

28 August 2017

Benjamin Clouzeau

4

1 reference

28 August 2017

Bui Hoang-Nam

5

1 reference

28 August 2017

Frédéric Vargas

6

1 reference

28 August 2017

Hilbert Gilles

7

1 reference

28 August 2017

Mathieu Molimard

8

1 reference

28 August 2017

Anne-Marie Rogues

9

1 reference

28 August 2017

Nicholas Moore

10

1 reference

28 August 2017

language of work or name

1 reference

1 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

36

1 reference

28 August 2017

4

1 reference

28 August 2017

217-230

1 reference

https://scigraph.springernature.com/pub.10.1007/s40264-013-0031-0

28 August 2017

0 references

cites work

Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Optimization of aminoglycoside therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Aminoglycoside drugs in clinical practice: an evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Do we still need the aminoglycosides?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Back to the future: using aminoglycosides again and how to dose them optimally

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Drug-associated renal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Acute renal failure in intensive care units--causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Gentamicin and gram-negative bacteremia. A synergism for the development of experimental nephrotoxic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Pharmacokinetic dosing of aminoglycosides: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

The use of a change in gentamicin clearance as an early predictor of gentamicin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Aminoglycoside nephrotoxicity: modeling, simulation, and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

An overview of drug-induced acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Once versus thrice daily gentamicin in patients with serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Case-control study of acute renal failure in patients with cystic fibrosis in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Aminoglycoside dosages and nephrotoxicity: quantitative relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmacokinetic-pharmacodynamic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Monitoring aminoglycoside use in patients with severely impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Pharmacist-driven aminoglycoside quality improvement program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Gentamicin-associated acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Does aminoglycoside therapy cause significant acute kidney injury in febrile neutropenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Efficacy and safety of once-daily amikacin in combination with ceftazidime in critically ill adults with severe gram-negative infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Experience with a once-daily dosing program of aminoglycosides in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Algorithm for assessing renal dysfunction risk in critically ill trauma patients receiving aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

More data on epidemiology and outcome of acute kidney injury with AKIN criteria: benefits of standardized definitions, AKIN and RIFLE classifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Evaluation of "Loss" and "End stage renal disease" after acute kidney injury defined by the Risk, Injury, Failure, Loss and ESRD classification in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

A concept for pharmacokinetic-pharmacodynamic dosage adjustment in renal impairment: the case of aminoglycosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Risk factors for toxicity in elderly patients given aminoglycosides once daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Management of aminoglycosides in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Endotoxemia, renal hypoperfusion, and fever: interactive risk factors for aminoglycoside and sepsis-associated acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Effect of a single dose of tobramycin on systemic inflammatory response-induced acute kidney injury in a 6-hour porcine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Diuretics, mortality, and nonrecovery of renal function in acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Contrast-induced nephropathy--prevention and risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Suboptimal aminoglycoside dosing in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Amikacin Bayesian forecasting in critically ill patients with sepsis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Optimizing use of aminoglycosides in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

A prospective randomised trial comparing individualised pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Does once-daily dosing prevent nephrotoxicity in all aminoglycosides equally?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Antibiotic dosing in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Critical care of the bariatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Evaluation of four once-daily aminoglycoside dosing nomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Usefulness of estimating individual pharmacokinetic data for aminoglycoside therapy in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

The economic impact of once-daily versus conventional administration of gentamicin and tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

An information campaign on aminoglycosides use during septic shock failed to improve the quality of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Gender differences in aminoglycoside induced nephrotoxicity: a prospective, hospital-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Gentamicin volume of distribution in critically ill septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0031-0

Low serum albumin and the increased risk of amikacin nephrotoxicity

21 January 2018

1 reference

12 December 2020

The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function

1 reference

12 December 2020

Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin

1 reference

12 December 2020

Prospective audit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes.

1 reference

12 December 2020

Does accepting pharmacokinetic recommendations impact hospitalization? A cost-benefit analysis

1 reference

12 December 2020

Fluctuation of the volume of distribution of amikacin and its effect on once-daily dosage and clearance in a seriously ill patient

1 reference

12 December 2020

Aminoglycosides: nephrotoxicity

1 reference

12 December 2020

Continuous arteriovenous hemofiltration of aminoglycoside antibiotics in critically ill patients

1 reference

12 December 2020

Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity

1 reference

12 December 2020

Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients

1 reference

12 December 2020

Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man

1 reference

12 December 2020

A model for predicting nephrotoxicity in patients treated with aminoglycosides

1 reference

12 December 2020

Gentamicin dosing errors with four commonly used nomograms

1 reference

12 December 2020

Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy

1 reference

12 December 2020

Pharmacokinetics of amikacin during continuous veno-venous hemofiltration

1 reference

12 December 2020

Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods

1 reference

12 December 2020

Increased burn patient survival with individualized dosages of gentamicin

1 reference

12 December 2020

What is the cost of nephrotoxicity associated with aminoglycosides?

1 reference

12 December 2020

Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy.

1 reference

12 December 2020

Gentamicin nephrotoxicity in the setting of acute renal hypoperfusion

1 reference

12 December 2020

Update on drug sieving coefficients and dosing adjustments during continuous renal replacement therapies.

1 reference

12 December 2020

Appropriateness of a 4 mg/kg gentamicin or tobramycin loading dose in post-operative septic shock patients

1 reference

12 December 2020

Clinical predictors of subtherapeutic aminoglycoside levels in trauma patients undergoing once-daily dosing

1 reference

12 December 2020

Renal tolerability of four different once-daily dose regimen of netilmicin in critical care patients

1 reference

12 December 2020

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

1 reference

12 December 2020

Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a cost-benefit analysis.

1 reference

12 December 2020

Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis

1 reference

12 December 2020

Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients

1 reference

12 December 2020

Aminoglycoside-associated nephrotoxicity in the elderly

1 reference

12 December 2020

Gentamicin and acute kidney injury requiring renal replacement therapy in the context of a restrictive antibiotic policy

1 reference

12 December 2020

Factors affecting gentamicin pharmacokinetics in septic patients

1 reference

12 December 2020

Amikacin nephrotoxicity in patients with chronic liver disease

1 reference

12 December 2020

Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults

1 reference

12 December 2020

Comparative studies on the action of aminoglycosides and cephalosporins on the proximal tubule of the human kidney

1 reference

12 December 2020

Pharmacoeconomic impact of once-daily aminoglycoside administration

1 reference

12 December 2020

Gentamicin clearance during continuous arteriovenous hemodiafiltration.

1 reference

12 December 2020

Physiologic response of stress and aminoglycoside clearance in critically ill patients

1 reference

12 December 2020

Aminoglycoside dosage in hemodialysis patients

1 reference

12 December 2020

A Randomized Clinical Trial of Moxalactam Alone versus Tobramycin plus Clindamycin in Abdominal Sepsis

1 reference

12 December 2020

Administration of aminoglycosides to hemodialysis patients immediately before dialysis: a new dosing modality

1 reference

12 December 2020

Optimizing tobramycin therapy in a hemodialysis patient

1 reference

12 December 2020

Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function

1 reference

12 December 2020

Aminoglycoside volume of distribution and illness severity in critically ill septic patients

1 reference

12 December 2020

The clinical utility of a published nomogram to predict aminoglycoside nephrotoxicity

1 reference

12 December 2020

Prediction of serum gentamicin concentrations in patients undergoing hemodialysis

1 reference

12 December 2020

Evaluation of a Bayesian method of amikacin dosing in intensive care unit patients with normal or impaired renal function.

1 reference

12 December 2020

Population pharmacokinetics of amikacin in critically ill patients

1 reference

12 December 2020

Development of a Semimechanistic Model to Describe the Pharmacokinetics of Gentamicin in Patients Receiving Hemodialysis

1 reference

12 December 2020

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients

1 reference

12 December 2020

Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia

1 reference

12 December 2020

Variability in aminoglycoside pharmacokinetics in critically ill surgical patients

1 reference

12 December 2020

Assessment of the enzymuria resulting from gentamicin alone and combinations of gentamicin with various beta-lactam antibiotics

1 reference

12 December 2020

Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria

1 reference

12 December 2020

Impact of aminoglycoside serum assays on clinical decisions and renal toxicity

1 reference

12 December 2020

An approach to forecast aminoglycoside-related nephrotoxicity from routinely collected clinical data

1 reference

12 December 2020

Cost-benefit analysis of an aminoglycoside monitoring service

1 reference

12 December 2020

Gentamicin disposition and tissue accumulation on multiple dosing

1 reference

12 December 2020

National survey of extended-interval aminoglycoside dosing

1 reference

12 December 2020

Comparison of four methods of predicting serum gentamicin concentrations in adult patients with impaired renal function.

1 reference

12 December 2020

Audit of prescription and assay of aminoglycosides in a UK teaching hospital

1 reference

12 December 2020

Effect of furosemide on the pharmacokinetics of gentamicin in patients

1 reference

12 December 2020

10.1007/S40264-013-0031-0

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference